GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raily Aesthetic Medicine International Holdings Ltd (HKSE:02135) » Definitions » Piotroski F-Score

Raily Aesthetic Medicine International Holdings (HKSE:02135) Piotroski F-Score : 5 (As of Jun. 18, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Raily Aesthetic Medicine International Holdings Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Raily Aesthetic Medicine International Holdings has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Raily Aesthetic Medicine International Holdings's Piotroski F-Score or its related term are showing as below:

HKSE:02135' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 6   Max: 6
Current: 5

During the past 7 years, the highest Piotroski F-Score of Raily Aesthetic Medicine International Holdings was 6. The lowest was 1. And the median was 6.


Raily Aesthetic Medicine International Holdings Piotroski F-Score Historical Data

The historical data trend for Raily Aesthetic Medicine International Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raily Aesthetic Medicine International Holdings Piotroski F-Score Chart

Raily Aesthetic Medicine International Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial 6.00 6.00 1.00 5.00 -

Raily Aesthetic Medicine International Holdings Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 - 5.00 - -

Competitive Comparison of Raily Aesthetic Medicine International Holdings's Piotroski F-Score

For the Medical Care Facilities subindustry, Raily Aesthetic Medicine International Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raily Aesthetic Medicine International Holdings's Piotroski F-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raily Aesthetic Medicine International Holdings's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Raily Aesthetic Medicine International Holdings's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec22) TTM:Last Year (Dec21) TTM:
Net Income was HK$-17.8 Mil.
Cash Flow from Operations was HK$-2.5 Mil.
Revenue was HK$183.7 Mil.
Gross Profit was HK$74.6 Mil.
Average Total Assets from the begining of this year (Dec21)
to the end of this year (Dec22) was (422.105 + 337.975) / 2 = HK$380.04 Mil.
Total Assets at the begining of this year (Dec21) was HK$422.1 Mil.
Long-Term Debt & Capital Lease Obligation was HK$38.6 Mil.
Total Current Assets was HK$125.7 Mil.
Total Current Liabilities was HK$85.3 Mil.
Net Income was HK$-21.7 Mil.

Revenue was HK$230.6 Mil.
Gross Profit was HK$85.3 Mil.
Average Total Assets from the begining of last year (Dec20)
to the end of last year (Dec21) was (322.831 + 422.105) / 2 = HK$372.468 Mil.
Total Assets at the begining of last year (Dec20) was HK$322.8 Mil.
Long-Term Debt & Capital Lease Obligation was HK$48.6 Mil.
Total Current Assets was HK$184.9 Mil.
Total Current Liabilities was HK$141.2 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Raily Aesthetic Medicine International Holdings's current Net Income (TTM) was -17.8. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Raily Aesthetic Medicine International Holdings's current Cash Flow from Operations (TTM) was -2.5. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec21)
=-17.768/422.105
=-0.04209379

ROA (Last Year)=Net Income/Total Assets (Dec20)
=-21.662/322.831
=-0.06710012

Raily Aesthetic Medicine International Holdings's return on assets of this year was -0.04209379. Raily Aesthetic Medicine International Holdings's return on assets of last year was -0.06710012. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Raily Aesthetic Medicine International Holdings's current Net Income (TTM) was -17.8. Raily Aesthetic Medicine International Holdings's current Cash Flow from Operations (TTM) was -2.5. ==> -2.5 > -17.8 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=38.588/380.04
=0.10153668

Gearing (Last Year: Dec21)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec20 to Dec21
=48.604/372.468
=0.13049175

Raily Aesthetic Medicine International Holdings's gearing of this year was 0.10153668. Raily Aesthetic Medicine International Holdings's gearing of last year was 0.13049175. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec22)=Total Current Assets/Total Current Liabilities
=125.697/85.332
=1.47303473

Current Ratio (Last Year: Dec21)=Total Current Assets/Total Current Liabilities
=184.914/141.184
=1.30973765

Raily Aesthetic Medicine International Holdings's current ratio of this year was 1.47303473. Raily Aesthetic Medicine International Holdings's current ratio of last year was 1.30973765. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Raily Aesthetic Medicine International Holdings's number of shares in issue this year was 480.595. Raily Aesthetic Medicine International Holdings's number of shares in issue last year was 480.188. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=74.578/183.724
=0.4059241

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=85.336/230.649
=0.36998209

Raily Aesthetic Medicine International Holdings's gross margin of this year was 0.4059241. Raily Aesthetic Medicine International Holdings's gross margin of last year was 0.36998209. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec21)
=183.724/422.105
=0.43525663

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec20)
=230.649/322.831
=0.71445741

Raily Aesthetic Medicine International Holdings's asset turnover of this year was 0.43525663. Raily Aesthetic Medicine International Holdings's asset turnover of last year was 0.71445741. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+1+1+0+1+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Raily Aesthetic Medicine International Holdings has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Raily Aesthetic Medicine International Holdings  (HKSE:02135) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Raily Aesthetic Medicine International Holdings Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Raily Aesthetic Medicine International Holdings's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Raily Aesthetic Medicine International Holdings (HKSE:02135) Business Description

Traded in Other Exchanges
N/A
Address
No. 290 North Zhongshan Road, 3-5th Floor, Minhang Tower, Gongshu District, Hangzhou, CHN
Raily Aesthetic Medicine International Holdings Ltd is an aesthetic medical service provider in Zhejiang Province, the PRC. It offers a broad range of aesthetic medical services to clients to meet their different aesthetic and anti-aging objectives. The group is organized into business units based on their services and has three reportable operating segments namely Aesthetic medical services which comprise principally inpatient services including surgical services and outpatient services including injection service, dermatology services, and others; and Consulting service segment which comprise principally management consulting services. Aesthetic medical equipment products comprise principally sales of surgical implants and aesthetic medical skincare products.
Executives
Fu Haishu 2201 Interest of corporation controlled by you
Jin Chunmiao 2202 Interest of your spouse
Ruide Consultation Limited 2101 Beneficial owner
Youxin Management Co., Limited 2101 Beneficial owner
Beauty Milkway (hk) Limited
China Orient Asset Management (international) Holding Limited
China Orient Asset Management Co., Ltd.
Dong Yin Development (holdings) Limited
Wise Leader Assets Ltd.
Shang Hai Dong Hua Jian Kang Guan Li He Huo Qi Ye You Xian He Huo
Dong Fang Zi Chan Guan Li Zhong Guo Kong Gu You Xian Gong Si
Shen Zhen Dong Fang Chuang Ye Tou Zi You Xian Gong Si
Shen Zhen Qian Hai Cai Fu Dong Fang Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si
Qing Hai Sheng Dong Fang Cang Yi Yao Chan Ye Fa Zhan Ji Jin You Xian He Huo
Qing Hai Sheng Dong Fang Cang Yi Yao Chan Ye Tou Zi Guan Li You Xian Gong Si

Raily Aesthetic Medicine International Holdings (HKSE:02135) Headlines

No Headlines